Pharmacology
- Estrogen Receptor Antagonist in Breast: via its active metobolite, hydroxytamoxifen
- Estrogen Receptor Agonist in Endometrium
Clinical Indications
- Estrogen Receptor-Positive Breast Cancer (see Breast Cancer)
Adverse Effects
- Hypercoagulable State (see Hypercoagulable States)
- Pulmonary Infiltrates with Eosinophilia (see Drug-Induced Pulmonary Eosinophilia)
References
- xxx